2-methyl-3-[(E)-[5-(4-methylphenyl)-1H-pyrazol-4-yl]methylideneamino]quinazolin-4-one
C20H17N5O — CID 135549728
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-methyl-3-[(E)-[5-(4-methylphenyl)-1H-pyrazol-4-yl]methylideneamino]quinazolin-4-one
2-methyl-3-[(E)-[5-(4-methylphenyl)-1H-pyrazol-4-yl]methylideneamino]quinazolin-4-one (PubChem CID 135549728) has the molecular formula C20H17N5O and a molecular weight of 343.39 g/mol. Its IUPAC name is 2-methyl-3-[(E)-[5-(4-methylphenyl)-1H-pyrazol-4-yl]methylideneamino]quinazolin-4-one.
Molecular Properties
| Compound Name | 2-methyl-3-[(E)-[5-(4-methylphenyl)-1H-pyrazol-4-yl]methylideneamino]quinazolin-4-one |
|---|---|
| PubChem CID | 135549728 |
| Molecular Formula | C20H17N5O |
| Molecular Weight | 343.39 g/mol |
| Exact Mass | 343.14 |
| IUPAC Name | 2-methyl-3-[(E)-[5-(4-methylphenyl)-1H-pyrazol-4-yl]methylideneamino]quinazolin-4-one |
| SMILES | Cc1ccc(-c2[nH]ncc2/C=N/n2c(C)nc3ccccc3c2=O)cc1 |
| InChI | InChI=1S/C20H17N5O/c1-13-7-9-15(10-8-13)19-16(11-21-24-19)12-22-25-14(2)23-18-6-4-3-5-17(18)20(25)26/h3-12H,1-2H3,(H,21,24)/b22-12+ |
| InChIKey | CEXFNDZVSGGKHD-WSDLNYQXSA-N |
| XLogP | 3.29 |
| TPSA | 75.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 343.39 |
| LogP ≤ 5 | 3.29 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135549728 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.